Massachusetts Financial Services CO Atea Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
SELL
$5.49 - $8.79 $2,552 - $4,087
-465 Reduced 0.9%
51,137 $291,000
Q2 2022

Aug 09, 2022
BUY
$5.33 - $8.18 $1,380 - $2,118
259 Added 0.5%
51,602 $366,000
Q1 2022

May 11, 2022
BUY
$5.5 - $9.19 $2,898 - $4,843
527 Added 1.04%
51,343 $371,000
Q4 2021

Feb 10, 2022
BUY
$7.67 - $44.59 $389,758 - $2.27 Million
50,816 New
50,816 $454,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $281M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email